Oral Corticosteroids for Teprotumumab-Related Hearing Loss: A Case Report
Case Reports in Ophthalmology · 04.04.2023 · 134-139
DOI: 10.1159/000529422 ↗Kurz gefasst
Fallbericht in der Zeitschrift Case Reports in Ophthalmology, online erschienen am 04.04.2023. Verfasst von Tracy J Lu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Byers Eye Institute, Stanford University School of Medicine, Palo Alto, CA, USA. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NEI NIH HHS.
Abstract (Originalsprache)
Teprotumumab is a novel insulin-like growth factor-1 receptor inhibitor approved for the treatment of thyroid eye disease, but growing reports of hearing loss require further investigation. To date, an effective protocol for managing hearing loss in this setting has not been determined. Here, we present the first report of the resolution of teprotumumab-related hearing loss with prompt oral prednisone. A 70-year-old woman on teprotumumab experienced sudden hearing loss and tinnitus after her first infusion. An audiogram demonstrated a mild down-sloping to moderately severe mixed conductive and sensorineural hearing loss that was promptly treated with prednisone 60 mg for 6 days with a 1-week gradual taper. An audiogram 3 weeks later demonstrated return of hearing to normal thresholds, and the whole teprotumumab treatment course was completed without further issue. This case highlights the importance of audiometric monitoring, prompt identification of hearing symptoms, and the potential for oral steroids to reverse teprotumumab-related hearing loss.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Byers Eye Institute, Stanford University School of Medicine, Palo Alto, CA, USA.
- Department of Ophthalmology, University of California San Francisco, San Francisco, CA, USA.
- Ear Associates, Inc., San Jose, CA, USA.
- Division of Endocrinology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Förderung
- NEI NIH HHS
Zitieren
APA
Lu, T. J., Amarikwa, L., Winn, B. J., Inserra, M., Dosiou, C., & Kossler, A. L. (2023). Oral Corticosteroids for Teprotumumab-Related Hearing Loss: A Case Report. Case Reports in Ophthalmology, 134-139. https://doi.org/10.1159/000529422
Vancouver
Lu TJ, Amarikwa L, Winn BJ, Inserra M, Dosiou C, Kossler AL. Oral Corticosteroids for Teprotumumab-Related Hearing Loss: A Case Report. Case Reports in Ophthalmology. 2023:134-139. doi:10.1159/000529422
BibTeX
@article{Lu2023,
author = {Lu, Tracy J and Amarikwa, Linus and Winn, Bryan J and Inserra, Michelle and Dosiou, Chrysoula and Kossler, Andrea L},
title = {Oral Corticosteroids for Teprotumumab-Related Hearing Loss: A Case Report},
journal = {Case Reports in Ophthalmology},
year = {2023},
pages = {134--139},
doi = {10.1159/000529422}
}
EUVIMED